Govt Job: For M.Pharm at ACTREC | Salary upto Rs. 40,000 pm

The Tata Memorial Center is an autonomous grant-in-aid institution of the Department of Atomic Energy.

TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH).

ACTREC conducts a Ph.D. program in Life Sciences, affiliated to the Homi Bhabha National Institute (a deemed university under category A by MHRD, Govt of India).

On-going research at ACTREC includes basic and translational research in Cancer Biology.

To work on a project entitled “Animal Oncology Program.”

Post : Junior Project Staff

Education Qualification and Experience :-PG in Science (M.Pharm, Life Sciences, Bio-technology, Nuclear Medicine) with 60% marks. A minimum of 1 year of work experience in a research laboratory in cell culture, immunochemistry, and animal experimentation/handling.

Consolidated Salary : Rs.18,000/- – 40,000/- per month.

Duration : Six Months. The work progress of the candidate will be monitored and extension after 6 months will depend on satisfactory progress of the work.

Eligible candidates may attend the walk in interview on Tuesday, February 15, 2022 at Meeting Room – I (354-A), 3rd Floor, Khanolkar Shodhika, ACTREC, along with a recent CV & original and attested copies of all certificates and testimonials with recent passport size photographs.

Reporting Time : 10.00 a.m. to 10.30.am.

Related Posts

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Stem cell therapy for autism illegal: NMC advisory

New Delhi:  The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha